Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)

This study has been withdrawn prior to enrollment.
(Study halted prior to enrollment of first participant)
Sponsor:
Collaborators:
PharmaNet
Nextrials, Inc.
Information provided by (Responsible Party):
Shire
ClinicalTrials.gov Identifier:
NCT01093105
First received: March 24, 2010
Last updated: February 19, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given